Dashboard
Manage Tickers

ICADICAD INC

Nasdaq icadmed.com


$ 1.78 $ 0.20 (12.66 %)    

Wednesday, 15-May-2024 11:32:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 450.54 $ 1.58 (0.35 %)
DIA $ 398.09 $ 2.51 (0.63 %)
SPY $ 527.87 $ 1.95 (0.37 %)
TLT $ 92.04 $ 1.18 (1.3 %)
GLD $ 220.26 $ 2.17 (1 %)
$ 1.58
$ 1.80
$ 0.00 x 0
$ 0.00 x 0
$ 1.78 - $ 1.80
$ 1.05 - $ 3.97
128,493
na
41.93M
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-30-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-11-2017 03-31-2017 10-Q
30 03-24-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-13-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

icad-q1-adj-005-beats-006-estimate-sales-495m-beat-444m-estimate
icad Q1 Adj $(0.05) Beats $(0.06) Estimate...
05/15/2024 12:02:34

icad (NASDAQ:ICAD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67...

icad-and-densitas-partner-to-enhance-precision-breast-health-with-leading-ai-solutions
iCAD And Densitas Partner To Enhance Preci...
04/09/2024 12:01:19

icads-profound-ai-suite-uncovers-hidden-heart-disease-risk-according-to-new-data-presented-at-acc-meeting
iCAD's ProFound AI Suite Uncovers Hidden H...
04/08/2024 20:30:46

icad-partners-with-rad-aid-to-advance-breast-cancer-detection-using-ai-in-underserved-regions
iCAD Partners With RAD-AID To Advance Brea...
04/03/2024 12:06:41

icad-q4-earnings-insights
icad: Q4 Earnings Insights
03/12/2024 20:10:17

icad-q4-2023-adj-eps-002-beats-005-estimate-sales-4741m-beat-4300m-estimate
icad Q4 2023 Adj EPS $(0.02) Beats $(0.05)...
03/12/2024 20:06:23

icad (NASDAQ:ICAD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.05) by 60 pe...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

earnings-outlook-for-icad
Earnings Outlook For icad
03/11/2024 17:01:01

icad-highlights-clinical-data-demonstrating-ability-to-reduce-breast-interval-cancer-rates-and-decrease-recall-rates-at-ecr-2024-showcases-additional-platform-offerings
iCAD Highlights Clinical Data Demonstratin...
02/28/2024 13:27:26

Clinical evidence demonstrates ProFound Detection's AI may help reduce breast interval cancer (IC) rates and decrease recal...

Core News & Articles
iCAD Announces Apps From The iCAD Breast H...
11/28/2023 13:13:44

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/28/2023 13:06:49

icads-profound-ai-can-predict-1-2-year-risk-for-breast-cancer-and-reveal-insights-for-heart-disease
iCAD's ProFound AI Can Predict 1-2 Year Ri...
11/27/2023 13:07:32

New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite...

icad-and-canceriq-have-announced-a-new-partnership-to-provide-a-seamless-way-to-inform-physicians-and-patients-of-cancer-risk-identify-breast-cancer-at-earlier-stages-when-treatments-work-best-and-increase-patient-adherence-to-personalized-care-plans
iCAD And CancerIQ Have Announced A New Par...
11/20/2023 13:02:42

recap-icad-q3-earnings
Recap: icad Q3 Earnings
11/13/2023 21:10:17

icad-q3-2023-gaap-eps-005-beats-008-estimate-sales-407m-miss-627m-estimate
icad Q3 2023 Gaap EPS $(0.05) Beats $(0.08...
11/13/2023 21:07:56

icad (NASDAQ:ICAD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 ...

earnings-scheduled-for-november-13-2023
Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

earnings-outlook-for-icad
Earnings Outlook For icad
11/10/2023 16:01:58

icad-inc-announces-sale-of-xoft-brachytherapy-business-line-to-elekta-for-55m
iCAD, Inc. Announces Sale Of Xoft Brachyth...
10/23/2023 12:09:50

icad-announced-health-canada-has-issued-a-device-license-for-profound-risk-version-20-the-latest-version-of-icads-personalized-1-2-year-breast-cancer-risk-assessment-solution
iCAD Announced Health Canada Has Issued A ...
08/16/2023 12:06:27

icad-q2-adj-007-up-from-012-yoy-sales-587m-down-from-758m-yoy
icad Q2 Adj $(0.07) Up From $(0.12) YoY, S...
08/14/2023 20:32:11

icad (NASDAQ:ICAD) reported quarterly losses of $(0.07) per share. This is a 41.67 percent increase over losses of $(0.12) per ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION